Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Sprangers

Showing results (151-160 of 182) with videos related to

Pageof 19
Sort By:
Frontiers in Immunology|March 14, 2022
Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological FindingsElisabet Van Loon, Baptiste Lamarthée, Thomas Barba, et al.
Journal of Onco-Nephrology|February 18, 2026
Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United StatesSamhita Boppana, Christopher D Blosser, Allison B Webber, et al.
Kidney International|May 8, 2022
Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathologyElisabet Van Loon, Baptiste Lamarthée, Henriette de Loor, et al.
Journal of the American Society of Nephrology : JASN|August 9, 2020
Eplet Mismatch Load and <i>De Novo</i> Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort StudyAleksandar Senev, Maarten Coemans, Evelyne Lerut, et al.
The New England Journal of Medicine|November 8, 2013
Intrarenal resistive index after renal transplantationMaarten Naesens, Line Heylen, Evelyne Lerut, et al.
Plos Medicine|June 17, 2020
The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort studyRianne M Douwes, António W Gomes-Neto, Michele F Eisenga, et al.
Kidney International Reports|September 18, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous NephropathyBrad H Rovin, Pierre M Ronco, Jack F M Wetzels, et al.
Eclinicalmedicine|April 28, 2025
A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney functionGeeta Sandhu, Evangeline Armstrong Gordon, Josephine Adattini, et al.
Clinical Kidney Journal|June 27, 2022
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registryWim Laurens, Dries Deleersnijder, Amélie Dendooven, et al.
Journal of the American Society of Nephrology : JASN|July 10, 2020
Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific AntibodiesJasper Callemeyn, Evelyne Lerut, Henriette de Loor, et al.
Pageof 19

Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Frontiers in Immunology|March 14, 2022
Circulating Donor-Specific Anti-HLA Antibodies Associate With Immune Activation Independent of Kidney Transplant Histopathological FindingsElisabet Van Loon, Baptiste Lamarthée, Thomas Barba, et al.
Journal of Onco-Nephrology|February 18, 2026
Clinical practice pattern of management of plasma cell dyscrasia for kidney transplant candidates and recipients in the United StatesSamhita Boppana, Christopher D Blosser, Allison B Webber, et al.
Kidney International|May 8, 2022
Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathologyElisabet Van Loon, Baptiste Lamarthée, Henriette de Loor, et al.
Journal of the American Society of Nephrology : JASN|August 9, 2020
Eplet Mismatch Load and <i>De Novo</i> Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort StudyAleksandar Senev, Maarten Coemans, Evelyne Lerut, et al.
The New England Journal of Medicine|November 8, 2013
Intrarenal resistive index after renal transplantationMaarten Naesens, Line Heylen, Evelyne Lerut, et al.
Plos Medicine|June 17, 2020
The association between use of proton-pump inhibitors and excess mortality after kidney transplantation: A cohort studyRianne M Douwes, António W Gomes-Neto, Michele F Eisenga, et al.
Kidney International Reports|September 18, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous NephropathyBrad H Rovin, Pierre M Ronco, Jack F M Wetzels, et al.
Eclinicalmedicine|April 28, 2025
A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney functionGeeta Sandhu, Evangeline Armstrong Gordon, Josephine Adattini, et al.
Clinical Kidney Journal|June 27, 2022
Epidemiology of native kidney disease in Flanders: results from the FCGG kidney biopsy registryWim Laurens, Dries Deleersnijder, Amélie Dendooven, et al.
Journal of the American Society of Nephrology : JASN|July 10, 2020
Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific AntibodiesJasper Callemeyn, Evelyne Lerut, Henriette de Loor, et al.
Pageof 19